EyeYon Medical Overview
- Founded
- 2010
- Status
- Private
- Employees
- 19
- Latest Deal Type
- Series C
- Latest Deal Amount
- $25M
- Investors
- 12
EyeYon Medical General Information
Description
Developer of an ophthalmic contact lens designed to treat corneal edema. The company's lens is created for therapeutic use to promote corneal healing and relieve corneal pain during the treatment of acute or chronic pathologies and is non-invasive, comfortable, and simple to use, enabling patients to take complete care of their eyes.
Contact Information
Website
www.eye-yon.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Therapeutic Devices
Primary Office
- 3 Golda Meir Street
- 6th Floor
- Nes Ziona 7403648
- Israel
+972 000-000-0000
EyeYon Medical Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 6. Later Stage VC (Series C) | 15-Mar-2021 | $25M | 000.00 | Completed | Generating Revenue | |
| 5. Later Stage VC (Series B) | 21-Mar-2017 | 000 | 000.00 | 000.00 | Completed | Generating Revenue |
| 4. Accelerator/Incubator | 01-Jan-2016 | 00.000 | Completed | Generating Revenue | ||
| 3. Later Stage VC (Series A) | 05-Apr-2015 | 00.00 | 00.000 | 00.000 | Completed | Startup |
| 2. Early Stage VC | 28-Apr-2014 | $949K | $949K | 00.00 | Completed | Startup |
| 1. Accelerator/Incubator | Completed | Startup |
EyeYon Medical Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Preferred B | 000,000 | 00.000000 | 000.00 | 000.00 | 00 | 000.00 | 00.000 | |
| Preferred A2 | 00,000 | 00.000000 | 000.00 | 000.00 | 00 | 000.00 | 0.000 | |
| Preferred A1 | 000,000 | 00.000000 | 000.00 | 000.00 | 00 | 000.00 | 00.000 | |
| Preferred Seed 2 | 15,000 | $0.010000 | $12 | $12 | 1x | $12 | 2.75% | |
| Preferred Seed 1 | 330,000 | $0.010000 | $11.56 | $11.56 | 1x | $11.56 | 12.95% |
EyeYon Medical Patents
EyeYon Medical Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20210369443-A1 | Corneal implant injector system | Pending | 27-May-2020 | 000000000 | |
| US-20200170786-A1 | Corneal implant with peripheral skirt | Abandoned | 02-Dec-2018 | 0000000000 | 0 |
| US-20210128359-A1 | Treatment to improve adhesive properties of corneal implant | Granted | 08-Jan-2018 | 00000000000 | |
| EP-3709934-A1 | Treatment to improve adhesive properties of corneal implant | Pending | 08-Jan-2018 | 00000000000 | |
| JP-2021509631-A | Measures to improve the adhesive properties of corneal implants | Pending | 08-Jan-2018 | A61F9/00825 |
EyeYon Medical Executive Team (6)
EyeYon Medical Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %ile
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
Request a free trialEyeYon Medical Investors (12)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| Booth Park Capital | PE/Buyout | Minority | 000 0000 | 000000 0 | |
| Quark Venture | Venture Capital | Minority | 000 0000 | 000000 0 | |
| China Resources Capital Management | Corporate Venture Capital | Minority | 000 0000 | 000000 0 | |
| Diamond Capital (Taiwan) | Venture Capital | Minority | 000 0000 | 000000 0 | |
| Gauss (Roma) | Other | Minority | 000 0000 | 000000 0 |